FCER2 and mantle cell lymphoma: MCLs usually express pan-B-cell antigens (e.g., CD19 and CD20), CD5 and cyclin D1 but are negative for CD10 and CD23; only 5% of MCL patients lack expression of CD5 and cyclin D1 [5,6,7,8,9,17,25,26].